We Help Physicians and Patients in Planing Their Therapy Strategy

Individualized cancer therapy using our diagnostic services

Our company wants to enable cancer patients a longer survival and a better quality of life. For this purpose we concentrate on development and offering diagnostic services for cancer. These diagnostic services should help to adjust the treatment for a patient individually to make the therapy more successful.

So we follow the general medical principle below.

"The gods placed diagnosis before therapy."*

*Frequently quoted saying putatively from Prof. Franz Volhard (former director of the university hospital in Frankfurt a.M., Germany); source: Hessisches Ärzteblatt 7/2006, p. 499.

Based on this principle the physician tries to find the cause of a disease (diagnosis). On basis of this diagnosis the physician can initiate a proper treatment (therapy). If different therapy options exist, additional diagnostics can assist the selection. The selection of therapy decides whether a disease can be relieved or even healed.

diagnosis-before-therapy_en.png

Specifically for the improved selection of drugs for cancer treatment TherapySelct offers for patients and physicians two diagnostic services. These cancer diagnostics are called CTR-Test®icon_internal link-02_16x16.png und Caris Molecular Intelligence®icon_internal link-02_16x16.png.

This concept was also picked up by the new terms “personalized medicine”, “personalized oncology” and "precision medicine".

Important information regarding our diagnostics

  • Healing in cancer is difficult and demanding, depends on the therapies which exists, and might not be possible depending on the individual patient situation.
  • Diagnostic services can never be better than the therapeutic options that are evaluated. But finding potential effective treatment options for an individual patient can make cancer care more successful.
  • Our services are meant to support the existing cancer care. They are mostly used when no clear treatment regimen can be recommended. This is the situation for the following cases:
    • Several chemotherapeutic agents are equally suitable for treating a certain type of cancer (according to guidelines).
    • Recurrent tumors, when there are no guidelines available.
    • Origin of the tumor is unknown.
    • Rare tumor types, for which no guidelines exist.

Collaboration with Caris Life Sciences for biomarker profiling in cancer

We are excited to collaborate with the world-leading tumor profiling laboratory for analyzing biomarkersicon_internal link-02_16x16_FK.png:

Below you can find two videos, in which the company is introduced:

Caris - Company Introduction  Introduction of the company Caris Life Sciences

  Caris - Laboratory Introduction Introduction of the laboratory work at Caris Life Sciences